UBR5 and cancer: In vivo, SKOV3/UBR5−/− tumor bearing mice displayed reduced peritoneal tumor burden with impairment in peritoneal macrophage infiltration, spheroid formation, and cancer cell proliferation compared to controls (Fig. 7f–i).